Vitamin E or C does not reduce risk of dementia or Alzheimer's

Contrary to previous research, older adults who use over-the-counter vitamin E or C supplements do not have a reduced risk of developing dementia or Alzheimer’s disease. This is according to a new study published in the Journal of the American Geriatrics Society that tracked patients using vitamin E and/or vitamin C supplements over a follow-up period of more than 5 years.

The study also finds that the combined use of vitamins E and C, which was previously thought to offer even greater protection against the diseases, also did not reduce the risk of developing dementia or Alzheimer’s.

“There is limited evidence to support supplemental use of the vitamins to prevent or delay onset of Alzheimer’s disease, says Shelly L. Gray, author of the study. “In fact, other studies show that higher doses of vitamin E may even be associated with harm in older people, such as slightly increased risk of mortality.”

The exact cause of Alzheimer’s disease is not entirely known. One theory is that a high level of free radicals in the brain may contribute. Some vitamins, such as vitamin E, have the ability to neutralize free radicals, which might be expected to prevent injury to cells in the body that lead to disease. By taking doses of vitamin E that are higher than recommended for normal functioning of the body, it was hoped that cell injury from oxidant stress may be prevented, and that effect, if present, would result in less chance of developing Alzheimer’s.

Some older adults purchase even higher doses of vitamins E and C in the hope that they will prevent such diseases. The doses found in these supplements may be much higher than what is recommended for use by the general public and what is usually contained in a multivitamin.

At one point, vitamin E was touted as beneficial for preventing a wide variety of diseases and, therefore, this agent is still widely used. However, a growing body of evidence suggests that vitamin E also does not protect against cardiovascular disease or the many cancers thought to be inhibited through vitamin E intake. Many older adults may still believe that vitamin E is beneficial and may still be taking higher doses in hope of maintaining memory. Because vitamin E does not dissolve in water but instead in fat, it is harder for the body to rid itself of excess amounts of the vitamin.

Source: Blackwell Publishing Ltd.

Related stories:

Lack of vitamin D linked to Parkinson's disease
A majority of Parkinson's disease patients had insufficient levels of vitamin D in a new study from Emory University School of Medicine.
Clinical study to examine role of vitamin D in kidney disease
Vitamin D is the key to preventing rickets and osteoporosis, but Rockefeller University scientists suspect it may also play a role in heading off atherosclerosis in people with chronic kidney disease.
Low vitamin D levels pose large threat to health
Researchers at Johns Hopkins are reporting what is believed to be the most conclusive evidence to date that inadequate levels of vitamin D, obtained from milk, fortified cereals and exposure to sunlight, lead to substantially increased risk of death.
Seniors with type 2 diabetes may experience memory declines immediately after eating unhealthy meal
Adults with type 2 diabetes who eat unhealthy, high-fat meals may experience memory declines immediately afterward, but this can be offset by taking antioxidant vitamins with the meal, according to new research from Baycrest.
No association found between vitamin D concentration in blood and risk of prostate cancer
High vitamin D concentration in the blood is not associated with a reduced risk of prostate cancer, researchers report in an article published online May 27 in the Journal of the National Cancer Institute.
Jefferson scientists studying the effects of high-dose vitamin C on non-Hodgkin lymphoma patients
Vitamin C's low toxicity lends high hopes to pioneering study
Scientists at Thomas Jefferson University Hospital and Jefferson’s Kimmel Cancer Center have received approval for a first-of-its kind study on the effect high dose vitamin C has on non-Hodgkin lymphoma patients. Researchers from the Jefferson-Myrna Brind Center of Integrative Medicine and Kimmel Cancer Center in conjunction with the National Institutes of Health will study whether high doses of vitamin C can slow the progression of the deadly disease.

A vitamin B12 derivative could potentially be used to treat hypertension and heart disease
Investigators at the University of California, San Diego School of Medicine have developed a new drug called nitrosyl-cobinamide. Cobinamide is a vitamin B12 analog, and, in fact, is the penultimate compound in the biosynthesis of vitamin B12 by bacteria. The UCSD investigators have shown that cobinamide binds relatively tightly to nitric oxide (NO), forming nitrosyl-cobinamide.
Diet and medications may assist prevention of prostate cancer
Recent investigations of medications, diet and the molecular understanding of prostate cancer are defining potential prevention strategies for the disease, and herald a new stage in the management of this cancer, according to a new review.

News discussion:

Medicine & Health news